Dr Rhiannon Jenkinson (CSO) and Jody Sawyer (VP of Business Development) had a fantastic time at the IO conference in Boston, meeting with current clients and new companies. After spending time at the conference, visiting the Boston Biotech hub and dining with clients the Nexus BioQuest team were extremely grateful for the fruitful discussions and excited about future collaborations. The Nexus Team will be back in Boston in early 2024 to visit clients and later in the year for the Special AACR conference, see more on our Events page. If you are interested in meeting the team in March 2024 Contact Us

Nexus is very excited to be attending Oxford Global Immuno in London 25th-26st April 2024. Anna Willox Ex Director BD will be attending. If you are interested in learning more about Nexus BioQuest and how we can work together please contact us

Nexus is very excited to be attending AACRs special conference in cancer research: Tumour Immunology and Immunotherapy in Boston 18th-21st October 2024. Rhiannon Jenkinson CSO and Jody Sawyer VP Business Development NA will be attending. If you are interested in learning more about Nexus BioQuest and how we can work together please contact us

Nexus is very excited to be attending Swiss Biotech Day, Basel 22nd-23rd April 2024. Rhiannon Jenkinson CSO and Sarah Glennie CBO will be attending. If you are interested in learning more about Nexus BioQuest and how we can work together please contact us

Nexus is very excited to be attending SITC in San Diego 1st-5th November. Rhiannon Jenkinson CSO and Jody Sawyer VP Business Development NA will be attending. If you are interested in learning more about Nexus BioQuest and how we can work together please contact us or visit booth#1132

Immuno-Oncology Summit Boston 7-9th August 2023

Nexus is very excited to be attending the Immuno-Oncology Summit in Boston this year. Rhiannon Jenkinson CSO and Jody Sawyer VP Business Development NA will be attending. If you are interested in learning more about Nexus BioQuest and how we can work together please contact us.